PureHealth Research LLC, a US-based health and wellness company developing premium, science-backed dietary supplements, announced on Saturday that it has launched a new collection of natural GLP-1 supplements designed to support the body's own GLP-1 production, satiety signalling, and metabolic wellness.
The products have been developed with input from medical professionals and formulated with clinically studied botanicals, to help with endogenous GLP-1 production through targeted botanical compounds.
They feature nine synergistic, clinically studied ingredients for comprehensive metabolic health support.
PureHealth Research said that its natural GLP-1 supplements offer a doctor-approved, holistic approach to healthy weight management and blood sugar support already within the normal range.
GSK licences global rights to linerixibat to Alfasigma in USD300m deal
IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892
Servier signs definitive agreement with Day One Biopharmaceuticals
PyroGenesis completes plasma torch system for Constellium aluminium furnace project
Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial
Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort
Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM
Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
iLoF collaborates with Bluepharma to deploy AI-powered Optomics
Akeso agrees clinical trial collaboration with INOVIO
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Frontage Laboratories acquires Teddy Clinical Research Laboratory in China